Free Trial

LeMaitre Vascular (LMAT) Earnings Date, Estimates & Call Transcripts

LeMaitre Vascular logo
$92.12 -0.13 (-0.14%)
(As of 12/20/2024 05:16 PM ET)

LeMaitre Vascular Latest Earnings Summary

Actual EPS
(Oct. 31)
$0.49 Beat By $0.05
Consensus EPS
(Oct. 31)
$0.44

LeMaitre Vascular issued Q3 2024 earnings on October 31, 2024, reporting an EPS of $0.49, which beat the consensus estimate of $0.44 by $0.05. Quarterly revenue rose 15.6% year-over-year to $54.82 million, above the consensus estimate of $53.50 million. With a trailing EPS of $1.83 and a P/E Ratio of 50.34, LeMaitre Vascular's earnings are expected to grow 11.34% next year, from $1.94 to $2.16 per share.

Get LeMaitre Vascular Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on LeMaitre Vascular and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

LMAT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LMAT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

LeMaitre Vascular Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20241$0.40$0.40$0.400.360 - 0.410
Q2 20241$0.47$0.47$0.470.450 - 0.500
Q3 20241$0.40$0.40$0.400.420 - 0.460
Q4 20242$0.43$0.49$0.460.470 - 0.510
FY 20245$1.70$1.76$1.73 
Q1 20252$0.50$0.54$0.52 
Q2 20252$0.51$0.53$0.52 
Q3 20252$0.51$0.55$0.53 
Q4 20252$0.47$0.53$0.50 
FY 20258$1.99$2.15 $2.07

LeMaitre Vascular Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/31/2024Q3 2024$0.44$0.49+$0.05$0.49$53.50M$54.82M
8/1/2024Q2 2024$0.47$0.52+$0.05$0.52$54.98M$55.85M
5/2/2024Q1 2024$0.39$0.44+$0.05$0.44$51.50M$53.48M
2/27/2024Q4 2023$0.36$0.38+$0.02$0.38$49.01M$48.90M
11/1/2023Q3 2023$0.31$0.33+$0.02$0.33$47.58M$47.40M
8/1/2023Q2 2023$0.32$0.37+$0.05$0.38$48.29M$50.12M
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

5/2/2023Q1 2023$0.25$0.27+$0.02$0.27$43.54M$47.08M
2/23/2023Q4 2022$0.26$0.25 -$0.01$0.25$40.99M$41.00M

LeMaitre Vascular Earnings - Frequently Asked Questions

LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earning data on Thursday, October 31, 2024. Learn more on LMAT's earnings history.

LeMaitre Vascular issued an update on its FY 2024 earnings guidance on Thursday, October, 31st. The company provided earnings per share guidance of 1.910-1.960 for the period, compared to the consensus earnings per share estimate of 1.850. The company issued revenue guidance of $219.0 million-$221.0 million, compared to the consensus revenue estimate of $218.3 million.

In the previous quarter, LeMaitre Vascular (NASDAQ:LMAT) reported $0.49 earnings per share (EPS) to beat the analysts' consensus estimate of $0.44 by $0.05. Learn more on analysts' earnings estimate vs. LMAT's actual earnings.

The conference call for LeMaitre Vascular's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for LeMaitre Vascular's latest earnings report can be read online.
Read Transcript

LeMaitre Vascular (NASDAQ:LMAT) has a recorded annual revenue of $213.03 million.

LeMaitre Vascular (NASDAQ:LMAT) has a recorded net income of $30.10 million. LMAT has generated $1.83 earnings per share over the last four quarters.

LeMaitre Vascular (NASDAQ:LMAT) has a trailing price-to-earnings ratio of 50.34 and a forward price-to-earnings ratio of 47.48. The price/earnings-to-growth ratio is 2.47.

LeMaitre Vascular's earnings are expected to grow from $1.94 per share to $2.16 per share in the next year, which is a 11.34% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:LMAT) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners